-

Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) will showcase its latest mass spectrometry innovations at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics, scheduled for June 2 - 6, 2024, in Anaheim, California. A global leader in analytical instruments, Agilent continues to drive performance and accessibility in mass spectrometry.

“Agilent will make a significant impact at this year’s ASMS Conference, unveiling cutting-edge mass spectrometry solutions that deliver intelligence-driven performance that is beyond all limits,” exclaimed Ken Suzuki, vice president and general manager of Agilent’s Mass Spectrometry Division. "Our mission is more than simplifying lab operations; we provide solutions that enhance performance, streamline workflows, and provide powerful data insights, opening doors to new research frontiers.”

Agilent’s breakthroughs in mass spectrometry include the 6495D LC/TQ, an ultrahigh-performance instrument designed for research and testing labs analyzing large sample batches. It achieves parts per quadrillion (ppq)-level detection limits for challenging analytes in diverse sample matrices, such as omics, food, and environmental analysis.

In addition, Agilent’s Revident LC/Q-TOF is a next-generation, hybrid quadrupole time-of-flight mass spectrometer. It revolutionizes identification with rock-solid evidence, accurate mass measurements, and high-resolution data for targeted and untargeted analysis. Applications include food safety, metabolomics, and other discovery-based studies.

“Stay tuned for exciting announcements about additional GC/MS and LC/MS products and solutions launching at ASMS this year. These innovative offerings will provide next-level intelligence, unmatched sensitivity, and industry-leading robustness,” Suzuki added.

Agilent will hold several events at ASMS 2024, including two User Group Meetings (for LC/ Triple Quadrupole and Ion Mobility) on Sunday, June 2, from 9:30 a.m. to 4:30 p.m. at the Doubletree Hotel in Anaheim. Agilent will also host six breakfast sessions Monday, June 3, through Wednesday, June 5, from 7:00 to 8:00 a.m. at the Anaheim Convention Center (rooms 212 AB and 213 D) where key customers will present their research. Additional information on these and other events is available at Agilent at ASMS.

ASMS attendees are invited to visit Agilent's Exhibition Booth #300 at the Anaheim Convention Center and the Agilent Hospitality Suite at the Anaheim Marriott, Marquis Ballroom South, from Monday, June 3 to Wednesday, June 6, from 8:00 to 10:30 p.m. Agilent is a corporate member of ASMS and multi-year co-sponsor of the annual event.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies, Inc.
+1.978.314.1862
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies, Inc.
+1.978.314.1862
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving...

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time...

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the...
Back to Newsroom